Broward Health Medical Center | |
1600 S Andrews Ave, Fort Lauderdale, Florida 33316 | |
(954) 355-4400 | |
Name | Broward Health Medical Center |
---|---|
Type | Acute Care Hospital |
Location | 1600 S Andrews Ave, Fort Lauderdale, Florida |
Ownership | Government - Hospital District or Authority |
Emergency Services | Yes |
Medicare ID (CCN) | 100039 |
NPI Number | 1184899452 |
Organization Name | NORTH BROWARD HOSPITAL DISTRICT |
Doing Business As | BROWARD GENERAL MEDICAL CENTER |
Address | 1600 S Andrews Ave, Fort Lauderdale, FL 33316 |
Hospital Type | General Acute Care Hospital |
Phone Number | 954-847-4315 |
News Archive
St. Jude Medical, Inc., a global medical device company, announced today that it has received U.S. Food and Drug Administration (FDA) approval of two new irrigated ablation catheters - the Safire BLU™ Bi-directional Irrigated Ablation Catheter and the Therapy™ Cool Path™ bi-directional ablation catheter.
Convergence Pharmaceuticals Limited, the company focused on the development of novel and high value analgesic medicines, today announces that the multiple ascending dose Phase I study of the novel, first in class calcium channel blocker CNV2197944, for the treatment of chronic pain has been initiated.
Discovery of an unexpected protein-protein interaction has led University of Iowa scientists and colleagues to identify a drug that slows the progression of Amyotrophic Lateral Sclerosis (ALS) in mice and nearly doubles the animals' lifespan.
A Children's National Health System research team has uncovered a novel process by which the gene APOL1 contributes to renal disease, according to a paper published November 18 in the Journal of the American Society of Nephrology.
› Verified 4 days ago
NPI Number | 1184938466 |
Organization Name | BROWARD GENERAL MEDICAL CENTER |
Address | 1600 S Andrews Ave, Fort Lauderdale, FL 33316 |
Hospital Type | Chronic Disease Hospital |
Phone Number | 954-459-2091 |
News Archive
St. Jude Medical, Inc., a global medical device company, announced today that it has received U.S. Food and Drug Administration (FDA) approval of two new irrigated ablation catheters - the Safire BLU™ Bi-directional Irrigated Ablation Catheter and the Therapy™ Cool Path™ bi-directional ablation catheter.
Convergence Pharmaceuticals Limited, the company focused on the development of novel and high value analgesic medicines, today announces that the multiple ascending dose Phase I study of the novel, first in class calcium channel blocker CNV2197944, for the treatment of chronic pain has been initiated.
Discovery of an unexpected protein-protein interaction has led University of Iowa scientists and colleagues to identify a drug that slows the progression of Amyotrophic Lateral Sclerosis (ALS) in mice and nearly doubles the animals' lifespan.
A Children's National Health System research team has uncovered a novel process by which the gene APOL1 contributes to renal disease, according to a paper published November 18 in the Journal of the American Society of Nephrology.
› Verified 4 days ago
NPI Number | 1265803480 |
Organization Name | BROWARD HEALTH MEDICAL CENTER |
Address | 1600 S Andrews Ave, Fort Lauderdale, FL 33316 |
Hospital Type | General Acute Care Hospital |
Phone Number | 954-760-7171 |
News Archive
St. Jude Medical, Inc., a global medical device company, announced today that it has received U.S. Food and Drug Administration (FDA) approval of two new irrigated ablation catheters - the Safire BLU™ Bi-directional Irrigated Ablation Catheter and the Therapy™ Cool Path™ bi-directional ablation catheter.
Convergence Pharmaceuticals Limited, the company focused on the development of novel and high value analgesic medicines, today announces that the multiple ascending dose Phase I study of the novel, first in class calcium channel blocker CNV2197944, for the treatment of chronic pain has been initiated.
Discovery of an unexpected protein-protein interaction has led University of Iowa scientists and colleagues to identify a drug that slows the progression of Amyotrophic Lateral Sclerosis (ALS) in mice and nearly doubles the animals' lifespan.
A Children's National Health System research team has uncovered a novel process by which the gene APOL1 contributes to renal disease, according to a paper published November 18 in the Journal of the American Society of Nephrology.
› Verified 4 days ago
NPI Number | 1285662239 |
Organization Name | NORTH BROWARD HOSPITAL DISTRICT |
Doing Business As | BROWARD HEALTH MEDICAL CENTER |
Address | 1600 South Andrews Avenue, Fort Lauderdale, FL 33316 |
Hospital Type | General Acute Care Hospital |
Phone Number | 954-355-4400 |
News Archive
St. Jude Medical, Inc., a global medical device company, announced today that it has received U.S. Food and Drug Administration (FDA) approval of two new irrigated ablation catheters - the Safire BLU™ Bi-directional Irrigated Ablation Catheter and the Therapy™ Cool Path™ bi-directional ablation catheter.
Convergence Pharmaceuticals Limited, the company focused on the development of novel and high value analgesic medicines, today announces that the multiple ascending dose Phase I study of the novel, first in class calcium channel blocker CNV2197944, for the treatment of chronic pain has been initiated.
Discovery of an unexpected protein-protein interaction has led University of Iowa scientists and colleagues to identify a drug that slows the progression of Amyotrophic Lateral Sclerosis (ALS) in mice and nearly doubles the animals' lifespan.
A Children's National Health System research team has uncovered a novel process by which the gene APOL1 contributes to renal disease, according to a paper published November 18 in the Journal of the American Society of Nephrology.
› Verified 4 days ago
NPI Number | 1760938724 |
Organization Name | BROWARD HEALTH MEDICAL CENTER |
Address | 1600 S Andrews Ave, Fort Lauderdale, FL 33316 |
Hospital Type | General Acute Care Hospital |
Phone Number | 954-760-7172 |
News Archive
St. Jude Medical, Inc., a global medical device company, announced today that it has received U.S. Food and Drug Administration (FDA) approval of two new irrigated ablation catheters - the Safire BLU™ Bi-directional Irrigated Ablation Catheter and the Therapy™ Cool Path™ bi-directional ablation catheter.
Convergence Pharmaceuticals Limited, the company focused on the development of novel and high value analgesic medicines, today announces that the multiple ascending dose Phase I study of the novel, first in class calcium channel blocker CNV2197944, for the treatment of chronic pain has been initiated.
Discovery of an unexpected protein-protein interaction has led University of Iowa scientists and colleagues to identify a drug that slows the progression of Amyotrophic Lateral Sclerosis (ALS) in mice and nearly doubles the animals' lifespan.
A Children's National Health System research team has uncovered a novel process by which the gene APOL1 contributes to renal disease, according to a paper published November 18 in the Journal of the American Society of Nephrology.
› Verified 4 days ago
Able to receive lab results electronically | Yes |
Able to track patients' lab results, tests, and referrals electronically between visits | Yes |
News Archive
St. Jude Medical, Inc., a global medical device company, announced today that it has received U.S. Food and Drug Administration (FDA) approval of two new irrigated ablation catheters - the Safire BLU™ Bi-directional Irrigated Ablation Catheter and the Therapy™ Cool Path™ bi-directional ablation catheter.
Convergence Pharmaceuticals Limited, the company focused on the development of novel and high value analgesic medicines, today announces that the multiple ascending dose Phase I study of the novel, first in class calcium channel blocker CNV2197944, for the treatment of chronic pain has been initiated.
Discovery of an unexpected protein-protein interaction has led University of Iowa scientists and colleagues to identify a drug that slows the progression of Amyotrophic Lateral Sclerosis (ALS) in mice and nearly doubles the animals' lifespan.
A Children's National Health System research team has uncovered a novel process by which the gene APOL1 contributes to renal disease, according to a paper published November 18 in the Journal of the American Society of Nephrology.
› Verified 4 days ago
Broward Health Medical Center Acute Care Hospital Location: 1600 S Andrews Ave, Fort Lauderdale, Florida 33316 Phone: (954) 355-4400 | |
Holy Cross Hospital Acute Care Hospital Location: 4725 N Federal Hwy, Fort Lauderdale, Florida 33308 Phone: (954) 771-8000 | |
Broward Health Imperial Point Acute Care Hospital Location: 6401 N Federal Hwy, Fort Lauderdale, Florida 33308 Phone: (954) 776-8500 |